Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001558370-25-005334
Filing Date
2025-04-24
Accepted
2025-04-24 07:01:59
Documents
1
Period of Report
2024-12-31
Effectiveness Date
2025-04-24

Document Format Files

Seq Description Document Type Size
1 ARS acrs-20241231xars.pdf ARS 1607017
  Complete submission text file 0001558370-25-005334.txt   2208277
Mailing Address 701 LEE ROAD SUITE 103 WAYNE PA 19087
Business Address 701 LEE ROAD SUITE 103 WAYNE PA 19087 484-324-7933
Aclaris Therapeutics, Inc. (Filer) CIK: 0001557746 (see all company filings)

EIN.: 460571712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-37581 | Film No.: 25863545
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)